Cubosomes-active carriers in chemotherapy modern medicine

  • K. Vinod Kumar Professor, Department of Pharmaceutics, St. Ann’s College of Pharmacy
  • N. Priyanka Associate Professor, Department of Pharmaceutics, St. Ann’s College of Pharmacy, Chirala
  • SK. Sania Amreen Department of Pharmacy, St. Ann’s College, Chirala
  • N.Sri Lakshmi Tirupathamma Department of Pharmacy, St. Ann’s College, Chirala
  • J.Kiranmai Department of Pharmacy, St. Ann’s College, Chirala

Abstract

Cubosomes are lipid vesicles that are comparable to vesicular systems like liposomes. Cubosomes are created with certain amphiphilic lipids in the presence of a suitable stabilizer. Since its discovery and designation, self-assembled cubosomes as active drug delivery vehicles have drawn much attention and interest. Oral, ocular, transdermal, and chemotherapeutic are just a few of the drugs delivery method in which they are used. Cubosomes show tremendous potential in  drug nano formulation for cancer therapeutics because of their prospective advantage, which include high drug dispersal due to the structure of the cubic, large surface area a relatively simple manufacturing process, biodegradability, ability to encapsulate hydrophobic, hydrophilic, and amphiphilic compounds, mostly cubosomes look like a “honey combed” structure and are thermodynamically stable. Application of cubosomes includes treatment of skin, hair, and other body tissue using cubosomes-like vehicle activity of biological substance, regulated release of solubilized chemicals. Melanoma {cancer} therapy based on a size delivery system is the key to effectively targeting melanoma due to increased permeability and retention.

Keywords: Cubosomes, Nanoparicles, Honeycomb, Lipid, Anticancer Therapy

References

1. Lakshmi, N.; Yalavarthi, P.; Vadlamudi, H.; Thanniru, J.; Yaga, G.; K,H.Cubosomes as targeted drug delivery systems – A biopharmaceuticalapproach.Curr.DrugDiscov. Technol. 2014,11,181-,188.[CrossRef]
2. Rizwan,S.B.;Boyd,B.J.Cubosomes:Structure, preparation and use as an antigen delivery system. Subunit Vacc. Deliv. 2014,7,125-140
3. Bhosale RR,Osmani RA, Harkare BR, Ghodake PP. Cubosomes. The Inimitable Nanoparticulate Drug Carriers. Sch Acad J Pharm 2013;2:481-86
4. Enriquez J, Goldberg R. Transforming Life , Transforming Business:The Life -Science Harvard Bus Rev 2000;96-104
5. Patrick TS Biocontinuous Cubic Liquid Crystalline Phase and cubosome Personal care Delivery systems. 1-27
6. Murphy E. Targeted nanogel : A versatile platform for drug delivery to tumors . Across J ,: 2012 :972-82
7. Daharwal SJ, Verma E, Saudagar RB. Semi Solid dosage forms. FarmavitaNet.,2014;13:10
8. Spicer PT Hayden KL ,Lynch ML, Ofori-Boateng A, Burns JL . Novel process for production of cubic liquid crystalline nanoparticles (cubosomes). Langmuir,2001;18,17(19):5748-56
9. Spicer P. Cubosomes Processing Industrial NanoparticleTechnology Development . Chem. Eng. Res. Des 2005;83:1283-86
10. Lazzati V, Tardieu A, Gulik-krzywicki T, Rivas E, Ressi -Husson F. Structure of the cubic phases of lipid -water systems. Nature 1968;220:485-8
11. Larsson K. Two cubic phases in the monoolein -water system. Nature 1983;304:664-65
12. Karami Z and Hamidi M. (2016). Cubosomes:Remarkable drug delivery potential. Drug Discovery Today. 21,789-801
13. Urvi S, Dhiren D , Bhavin P,Patel U and Shah R. (2013) .OverviewOfCubosomes: A Nanoparticle .In .J of ph. and Integ . Life Sci.., 1(15), 36-47
14. Sagnella S and Drummond C.(2012). Drug delivery a nanomedicines approach . Australian Biochemist .(43),5-7.
15. Xin,P.;Ke,H.;Xinsheng, P.;Zhiwen, Y.;Lingzhen, Q.;Chune,Z.;Xintian,H.;Xuan ,S.; Linghui,D.;Ming,L;etal. Nanostructured cubosomes as advanced drug delivery system. Curr. Pharm. Design2013,19,6290-6294
16. Shah,M.; Paradkar, A. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzymes. Int.J. Pharm.2005,294,161-171[CrossRef]
17. PenogX:Zhou,Y:Han , k ;Qin, L; Dian ,Li,G ; Pan ,X ; Wu ,C.Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin . Drug Des .Devel . Ther.2015,9,4209.(CrossRef) (Pub Med)
18. Pawley , J. The development of field -emission scanning electron microscopy for imaging biologicalsurfaces . Scanning 1997,19,324-336
19. Ajazuddin ; Saraf, s. Application of novel drug delivery system for herbal formulations. Fitoterpia 2010, 81,680-689.(CrossRef) (Pubmed)
20. Yao, Y; Zhou ,Liu , L; Xu,Y; Chen, Q;WangY;Zhang ,J; Shao ,A. Nanoparticle- based drug delivery in cancer therapy and its role in overcoming drug resistance .front .Mol .biosci. 2020,7,193.(CrossRef)
Statistics
27 Views | 18 Downloads
How to Cite
K, V. K., N, P., SK, S. A., N, S. L. T., & J, K. (2025). Cubosomes-active carriers in chemotherapy modern medicine. Journal of Integral Sciences, 8(3), 55-58. https://doi.org/10.37022/jis.v8i3.121
Section
Review Article(s)